Skip to content

A CLINICAL STUDY ON THE EFFICACY OF JEEMOOTHA YAVAKSHARA VARTI ON ARSHA VIZ-VIZ HEMORRHOID.

A RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY OF JEEMOOTHAKA YAVAKSHARA VARTI ON ARSHA VIS-A-VIS HEMORRHOID - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054903
Enrollment
40
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

DrVidhya Menon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of both genders between age group of 20 to 60 years. 2.Hemorrhoids of 1st , 2nd , 3rd degree. 3.Patients having 1 or 2 hemorrhoidal mass. 4.Patients with primary hemorrhoids.

Exclusion criteria

Exclusion criteria: 1.Hemorrhoids with hereditary causes, birth defects, anatomical changes due to surgery, injury etc. 2. Hemorrhoids associated with other ano-rectal/colon condition like fissure, fistula-in-ano, sinus, abscess, pre diagnosed cases of malignancy, ulcerative colitis, polyps, vascular anomalies, portal hypertension will be excluded. 3. Physiological conditions like pregnancy. 4. Hemorrhoids that are thrombosed, strangulated, prolapsed rectum will be excluded. 5. Depending upon the position and degree, 4th degree hemorrhoids, secondary hemorrhoids and external hemorrhoids will be excluded.

Design outcomes

Primary

MeasureTime frame
Regression of hemorrhoidsTimepoint: 30 days

Secondary

MeasureTime frame
Arrest hemorrhoidal bleedingTimepoint: 1st week

Countries

India

Contacts

Public ContactDr Vidhya menon

Muniyal Institute Of Ayurveda Medical Sciences

gurushalya@yahoo.co.in08762822790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026